Prestige Consumer Healthcare Inc. (NYSE:PBH) Q3 2023 Earnings Call Transcript

Ronald Lombardi: No and I think a great example is what we did last year with the Akorn acquisition. So we were able to do a $225 million acquisition in the year added to our Eye Care platform, and still reduced leverage by about a half a point last year. So I think really, the message is that one as we get bigger, and generate increased levels of cash flow and lower our debt overtime, it gives us the ability to do transactions and not go back to the peak levels of leverage we saw historically, as we were building the business. In terms of M&A, if there is a compelling opportunity out there, it is really our job to figure out how to get it done within the right leverage profile for the company. So that is how we think about it. It is not really describing any limiter for us Mitch.

Mitchell Pinheiro: Okay, got it. That is all I have, thank you.

Ronald Lombardi: Thank you.

Operator: Thank you. Our next question will come from Anthony Lebiedzinski of Sidoti and Company LLC. Your line is open.

Unidentified Analyst: Hi good morning. This is in for Anthony. My first question is, can you comment on the level of pricing actions that you took in the quarter?

Christine Sacco: Sure. So we had announced pricing back at the beginning of the year really, for some of our brands have gone through a second round of pricing. We talked about two-thirds of our growth this year expected to come from pricing, which is essentially the cost savings, offsetting our inflationary pressures on the dollar-for-dollar basis for the year. So we talked about that being in the $15 million to $20 million range for the year. So the pricing that rolled through earlier in the year, certainly helped in the quarter.

Unidentified Analyst: Thank you and second question is given the slower economy are you guys seeing any meaningful changes to consumer behavior? If yes, like which categories?

Ronald Lombardi: In our categories, what we have seen overtime is that it tends to be the one of the last areas that might be impacted by a slowing economy or pinched wallets by the average consumer right. You wake up and somebody is shifting your household and you don’t feel well. It is something that you generally look to postpone or forget about – it continues to be an opportunity where you look for that trusted brand to take care of your health. So it is something we continue to monitor and take a look at but at this point, we don’t see it impacting our business.

Unidentified Analyst: Alright. Thank you and how much is e-commerce now as a percentage of revenue and what was the growth rate in the quarter?

Christine Sacco: Yes, e-commerce is now about 15% of our sales and the growth has been continued to be strong in the high single-digits.

Unidentified Analyst: Thank you. And lastly, I’m not sure if you guys answered that but it looks like you guys are just a guidance and I was just wondering why you guys – why the company is adjusting to guidance with 2023? I don’t know if I missed that. I apologize.

Christine Sacco: Sure. So what we did today is we narrowed the original guide that we had to the lower end of the range on the top-line. We talked about FX impacting the top line results a little worse – and it worsened a bit this quarter, from our previous expectations and the EPS guide at the lower end of the range really reflecting the top-line we just talked about.

Unidentified Analyst: Thank you so much. Thank you for taking my questions.